On Friday, Barclays adjusted its outlook on Acadia Healthcare (NASDAQ:ACHC) Company, Inc. (NASDAQ:ACHC), reducing its price target to $76.00 from the previous $83.00. The firm continues to hold an Overweight rating on the healthcare provider's shares. The revision follows recent events that have cast a shadow over the company, including legal and regulatory challenges, as well as heightened media scrutiny.
The analyst at Barclays noted the negative impact of these developments on Acadia Healthcare's stock, suggesting that the market's response might be an overreaction. Despite the challenges, the analyst believes that the financial liability from potential federal investigations would be manageable. This assessment is based on historical outcomes from similar situations, such as the settlement reached by Universal Health Services (NYSE:UHS) following an investigation that began with a Buzzfeed article in December 2016, which concluded with a $127 million settlement with the Department of Justice (DOJ) in July 2019.
Acadia Healthcare recently resolved a DOJ investigation covering activities from 2014 to 2017 with a $20 million settlement. This resolution is seen as mitigating the risks associated with new inquiries. The analyst also pointed out that while the company is experiencing regulatory scrutiny, it is also witnessing growth in patient volumes, which is expected to drive revenue growth.
The price target reduction reflects a change in the multiple applied to the company's projected 2025 EBITDA-NCI, down to 11 times from the previous 12 times. The analyst's commentary underscores a belief in the company's operational strengths despite the external pressures it currently faces.
In other recent news, Acadia Healthcare Company, Inc. has been in the spotlight for various developments. The company reported an 8.8% increase in revenue for the second quarter of 2024, reaching $796 million, and a 7.6% growth in adjusted EBITDA, despite the closure of two underperforming facilities. Acadia Healthcare is also on track to add approximately 1,200 beds this year, which indicates an expansion period.
The company is currently cooperating with a government investigation, with CEO Chris Hunter emphasizing Acadia's commitment to high-quality care and compliance. Acadia Healthcare has also been fined $1.39 million by the U.S. Securities and Exchange Commission for violating whistleblower protection regulations.
In addition, Acadia Healthcare is under investigation by the United States Attorney's Office for the Southern District of New York and the United States District Court for the Western District of Missouri concerning its patient admissions, length of stay, and billing procedures. These are some of the recent developments at Acadia Healthcare. The company continues to focus on delivering safe, high-quality care and maintaining transparency and compliance with legal requirements.
InvestingPro Insights
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) presents a mixed financial picture according to recent InvestingPro data. Despite the challenges highlighted in the article, the company's revenue growth remains solid, with a 10.07% increase over the last twelve months as of Q2 2024, reaching $3.06 billion. This aligns with the analyst's observation of growing patient volumes driving revenue growth.
InvestingPro Tips suggest that while ACHC was not profitable over the last twelve months, analysts predict the company will be profitable this year. This forecast supports Barclays' Overweight rating and indicates potential for financial recovery despite recent setbacks.
The company's market capitalization stands at $5.91 billion, reflecting its significant presence in the healthcare sector. With a price-to-book ratio of 2.38, investors are paying a premium for the company's assets, suggesting market confidence in ACHC's long-term prospects.
For readers interested in a deeper analysis, InvestingPro offers additional tips and metrics that could provide further insight into Acadia Healthcare's financial health and market position. Currently, there are 3 more InvestingPro Tips available for ACHC, which could be valuable for investors considering the stock in light of recent developments.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.